title: Does coronary artery bypass surgery affect metoprolol bioavailability.
abstract: BACKGROUND
  beta-blockers are commonly administered in patients with coronary artery bypass surgery (CABG). Despite this therapy, however, the incidence of postoperative atrial fibrillation (AF) is high (9-19%), and it is unknown why the beta-blockers do not reduce the incidence of AF more efficiently. In this pharmacokinetics study, in which the patients acted as their own controls, we have evaluated the bioavailability of perioperative metoprolol tablets in CABG surgery patients.
  
  
  METHODS
  Twelve male patients, aged 45-64 years, scheduled for CABG surgery were administered an initial 50 mg metoprolol tartrate tablet orally on the morning of the preoperative day and thereafter at 12-h intervals. Regular blood samples were collected up to 12 h after the first administration of the drug on the preoperative day as well on the first and third postoperative days. The plasma concentration for metoprolol was analyzed (limit of quantification = 0.001 mg/L) using liquid chromatography-tandem mass spectrometry.
  
  
  RESULTS
  The bioavailability of the metoprolol was significantly less on the first postoperative day, with AUC(0-12) values ranging from 0.7 to 17.1 (median: 7.2) mg min/L, than on the preoperative day, with AUC(0-12) values of 5.1-26.7 (12.6) mg min/L; however, it returned to the preoperative values on the third postoperative day, with AUC(0-12) values of 3.5-25.2 (15.2) mg min/L. Similar changes were observed in C(max) values: preoperative C(max) ranged between 0.026 and 0.123 (0.060) mg/L, on the first postoperative day, the C(max) ranged between 0.003 and 0.093 (0.025) mg/L, and on the third postoperative day, the C(max) ranged between 0.009 and 0.136 (0.061) mg/L. There was no correlation between the pharmacokinetic parameters and patient characteristics, but both the preoperative C(max) and C(60) correlated significantly with the postoperative C(max) (Pearson correlation coefficient: 0.61-0.72). One patient with one of the lowest rates and extent of metoprolol absorption developed AF.
  
  
  CONCLUSIONS
  This study indicates that the bioavailability of metoprolol is markedly reduced when administered in tablet form during the early phase after CABG.
authors.affiliation: Department of Cardiothoracic Surgery, Kuopio University Hospital, Kuopio, Finland.
authors.forename: Antti
authors.initials: A
authors.lastname: Valtola
authors.forename: Hannu
authors.initials: H
authors.lastname: Kokki
authors.forename: Merja
authors.initials: M
authors.lastname: Gergov
authors.forename: Ilkka
authors.initials: I
authors.lastname: Ojanperä
authors.forename: Veli-Pekka
authors.initials: VP
authors.lastname: Ranta
authors.forename: Tapio
authors.initials: T
authors.lastname: Hakala
mesh_terms: D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000493:pharmacokinetics* / Q000627:therapeutic use; D019540:Area Under Curve; D001281:Atrial Fibrillation / Q000517:prevention & control*; D001682:Biological Availability; D002853:Chromatography, Liquid; D001026:Coronary Artery Bypass; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D008790:Metoprolol / Q000493:pharmacokinetics* / Q000627:therapeutic use; D008875:Middle Aged; D011183:Postoperative Complications / Q000517:prevention & control; D053719:Tandem Mass Spectrometry
chemical_list: D000319:Adrenergic beta-Antagonists; D008790:Metoprolol